Hengehold Capital Management LLC grew its stake in Teleflex Incorporated (NYSE:TFX – Free Report) by 7.3% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,289 shares of the medical technology company’s stock after purchasing an additional 88 shares during the quarter. Hengehold Capital Management LLC’s holdings in Teleflex were worth $229,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Cromwell Holdings LLC increased its stake in Teleflex by 59.0% in the third quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company’s stock valued at $33,000 after purchasing an additional 49 shares in the last quarter. Avior Wealth Management LLC grew its holdings in shares of Teleflex by 190.6% in the 3rd quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company’s stock valued at $38,000 after buying an additional 101 shares during the period. Ashton Thomas Securities LLC acquired a new position in shares of Teleflex in the 3rd quarter valued at $40,000. True Wealth Design LLC increased its position in shares of Teleflex by 16,600.0% in the 3rd quarter. True Wealth Design LLC now owns 167 shares of the medical technology company’s stock valued at $41,000 after buying an additional 166 shares in the last quarter. Finally, GAMMA Investing LLC raised its stake in Teleflex by 131.1% during the 3rd quarter. GAMMA Investing LLC now owns 171 shares of the medical technology company’s stock worth $42,000 after buying an additional 97 shares during the period. 95.62% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
A number of research analysts have issued reports on TFX shares. Royal Bank of Canada decreased their target price on Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research note on Friday, November 1st. StockNews.com upgraded shares of Teleflex from a “hold” rating to a “buy” rating in a report on Thursday, November 28th. Needham & Company LLC reiterated a “hold” rating on shares of Teleflex in a report on Monday, December 16th. Mizuho dropped their price objective on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a report on Friday, November 1st. Finally, Truist Financial reduced their target price on shares of Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a research note on Wednesday, December 18th. Three research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $252.50.
Teleflex Stock Up 0.1 %
Teleflex stock opened at $180.95 on Friday. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a 1-year low of $171.69 and a 1-year high of $256.85. The company has a fifty day simple moving average of $183.07 and a 200 day simple moving average of $214.58. The company has a market cap of $8.40 billion, a P/E ratio of 35.97, a price-to-earnings-growth ratio of 1.79 and a beta of 1.16.
Teleflex (NYSE:TFX – Get Free Report) last announced its quarterly earnings data on Thursday, October 31st. The medical technology company reported $3.49 earnings per share for the quarter, beating the consensus estimate of $3.38 by $0.11. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The company had revenue of $764.40 million during the quarter, compared to analysts’ expectations of $768.68 million. During the same quarter last year, the company earned $3.64 EPS. Teleflex’s revenue for the quarter was up 2.4% compared to the same quarter last year. Research analysts anticipate that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.
Teleflex Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Monday, December 16th. Stockholders of record on Friday, November 15th were issued a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 0.75%. The ex-dividend date of this dividend was Friday, November 15th. Teleflex’s payout ratio is presently 27.04%.
About Teleflex
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
Read More
- Five stocks we like better than Teleflex
- How to Calculate Inflation Rate
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- Conference Calls and Individual Investors
- 3 Buy-and-Hold Stocks for Long-Term Growth
- There Are Different Types of Stock To Invest In
- Despite Short-Term Risks Freeport McMoran Worth a Look
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX – Free Report).
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.